A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

Clinical Trial Information

Trial Phone: 321-841-7246

Principal Investigator: Praveen Chatani, MD

Phase: III

Age Group: OLDER_ADULT

ClinicalTrials.gov ID: NCT07068074

Objective

This study compares two treatment groups to see which one better prevents the cancer from coming back over two years. It also looks at how patients feel and function over that time using a quality-of-life survey. The goal is to understand both how well the treatments work and how they impact patients’ daily lives.

Share:

Related Clinical Trials

A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination with Rilvegostomig in Participants with High-risk Muscle Invasive Urothelial Carcinoma (TROPION-Urothelial04)
An Interventional Phase III, Open-Label, Randomized Study to Evaluate Efficacy and Safety of PF-08634404 in Combination with Chemotherapy versus Pembrolizumab in Combination with Chemotherapy in Adult Participants with Advanced or Recurrent Mismatch Repair Proficient Endometrial Cancer
Study of a New Device for Severe Asthma (PULSAR)
A Randomized, Open-Label Phase III Study of Azenosertib versus Investigator's Choice of Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression